Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application

Vancouver, British Columbia, July 29, 2025 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for patent application No. 3243445 entitled, “Contact-Free Breath Analysis Device and Method” to the Company. Recently the U.S. Patent and Trademark Office issued a notice of allowance for the same patent application filed in the United States. A notice of allowance indicates that the patent application has been approved by an examiner and that the Company can move forward with obtaining the patent granted upon payment of certain fees fee within a specified timeframe. 

This patent application is centered on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology. The technology has wide-ranging utility and can be integrated into everyday environments such as vehicles, workplaces, or public kiosks and supports fast, reliable testing without requiring physical contact. The technology can be used in unmanned breath devices, offering real-time feedback through visual indicators and displays and is well-suited for applications in law enforcement, workplace safety, and public health monitoring.  The system intelligently adjusts its internal airflow and pump mechanisms based on the sampling method, ensuring accurate and hygienic analysis.

This patent application continues to augment Cannabix’s leadership position at the forefront of breath sampling and detection techniques and continues to grow the intellectual capital of Cannabix’s breath capture and analytics portfolio.  The Company will report on future material developments regarding its “Contact-Free Breath Analysis Device and Method” patent applications in due course.